vs

Side-by-side financial comparison of BuzzFeed, Inc. (BZFD) and 4D Molecular Therapeutics, Inc. (FDMT). Click either name above to swap in a different company.

4D Molecular Therapeutics, Inc. is the larger business by last-quarter revenue ($85.1M vs $56.5M, roughly 1.5× BuzzFeed, Inc.). 4D Molecular Therapeutics, Inc. runs the higher net margin — 22.8% vs -47.4%, a 70.2% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 0.6%). 4D Molecular Therapeutics, Inc. produced more free cash flow last quarter ($28.5M vs $-12.0M). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs 23.6%).

BuzzFeed, Inc. is an American Internet media, news, and entertainment company with a focus on digital media. Based in New York City, BuzzFeed was founded in 2006 by Jonah Peretti and John S. Johnson III to focus on tracking viral content. Kenneth Lerer, co-founder and chairman of The Huffington Post, started as a co-founder and investor in BuzzFeed and is now the executive chairman.

4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.

BZFD vs FDMT — Head-to-Head

Bigger by revenue
FDMT
FDMT
1.5× larger
FDMT
$85.1M
$56.5M
BZFD
Growing faster (revenue YoY)
FDMT
FDMT
+8508899.4% gap
FDMT
8508900.0%
0.6%
BZFD
Higher net margin
FDMT
FDMT
70.2% more per $
FDMT
22.8%
-47.4%
BZFD
More free cash flow
FDMT
FDMT
$40.5M more FCF
FDMT
$28.5M
$-12.0M
BZFD
Faster 2-yr revenue CAGR
FDMT
FDMT
Annualised
FDMT
5412.6%
23.6%
BZFD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BZFD
BZFD
FDMT
FDMT
Revenue
$56.5M
$85.1M
Net Profit
$-26.8M
$19.4M
Gross Margin
Operating Margin
-43.7%
17.3%
Net Margin
-47.4%
22.8%
Revenue YoY
0.6%
8508900.0%
Net Profit YoY
-186.4%
139.1%
EPS (diluted)
$-0.72
$0.43

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BZFD
BZFD
FDMT
FDMT
Q4 25
$56.5M
$85.1M
Q3 25
$46.3M
$90.0K
Q2 25
$46.4M
$15.0K
Q1 25
$36.0M
$14.0K
Q4 24
$56.2M
$1.0K
Q3 24
$55.6M
$3.0K
Q2 24
$41.1M
$5.0K
Q1 24
$37.0M
$28.0K
Net Profit
BZFD
BZFD
FDMT
FDMT
Q4 25
$-26.8M
$19.4M
Q3 25
$-7.4M
$-56.9M
Q2 25
$-10.8M
$-54.7M
Q1 25
$-12.7M
$-48.0M
Q4 24
$31.0M
Q3 24
$2.1M
$-43.8M
Q2 24
$-7.5M
$-35.0M
Q1 24
$-35.7M
$-32.4M
Operating Margin
BZFD
BZFD
FDMT
FDMT
Q4 25
-43.7%
17.3%
Q3 25
-12.9%
-67983.3%
Q2 25
-7.5%
-396373.3%
Q1 25
-38.1%
-383007.1%
Q4 24
7.0%
Q3 24
2.8%
-1704400.0%
Q2 24
-13.6%
-849120.0%
Q1 24
-63.4%
-136200.0%
Net Margin
BZFD
BZFD
FDMT
FDMT
Q4 25
-47.4%
22.8%
Q3 25
-16.1%
-63195.6%
Q2 25
-23.3%
-364386.7%
Q1 25
-35.2%
-342657.1%
Q4 24
55.2%
Q3 24
3.8%
-1461433.3%
Q2 24
-18.2%
-699060.0%
Q1 24
-96.5%
-115717.9%
EPS (diluted)
BZFD
BZFD
FDMT
FDMT
Q4 25
$-0.72
$0.43
Q3 25
$-0.20
$-1.01
Q2 25
$-0.28
$-0.98
Q1 25
$-0.33
$-0.86
Q4 24
$0.86
Q3 24
$0.05
$-0.79
Q2 24
$-0.20
$-0.63
Q1 24
$-0.98
$-0.66

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BZFD
BZFD
FDMT
FDMT
Cash + ST InvestmentsLiquidity on hand
$8.5M
$402.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$49.4M
$505.7M
Total Assets
$188.1M
$566.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BZFD
BZFD
FDMT
FDMT
Q4 25
$8.5M
$402.7M
Q3 25
$34.3M
$305.1M
Q2 25
$29.7M
$293.2M
Q1 25
$34.3M
$321.4M
Q4 24
$22.4M
$424.9M
Q3 24
$53.7M
$501.9M
Q2 24
$45.5M
$541.9M
Q1 24
$44.5M
$525.9M
Stockholders' Equity
BZFD
BZFD
FDMT
FDMT
Q4 25
$49.4M
$505.7M
Q3 25
$75.9M
$369.0M
Q2 25
$81.1M
$420.9M
Q1 25
$93.8M
$469.7M
Q4 24
$104.8M
$510.6M
Q3 24
$71.7M
$552.9M
Q2 24
$67.2M
$588.3M
Q1 24
$73.7M
$600.6M
Total Assets
BZFD
BZFD
FDMT
FDMT
Q4 25
$188.1M
$566.7M
Q3 25
$211.2M
$424.0M
Q2 25
$210.4M
$473.6M
Q1 25
$203.2M
$515.7M
Q4 24
$221.4M
$560.4M
Q3 24
$276.5M
$604.0M
Q2 24
$272.9M
$620.1M
Q1 24
$299.0M
$629.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BZFD
BZFD
FDMT
FDMT
Operating Cash FlowLast quarter
$-11.7M
$28.6M
Free Cash FlowOCF − Capex
$-12.0M
$28.5M
FCF MarginFCF / Revenue
-21.2%
33.5%
Capex IntensityCapex / Revenue
0.5%
0.1%
Cash ConversionOCF / Net Profit
1.47×
TTM Free Cash FlowTrailing 4 quarters
$-20.7M
$-109.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BZFD
BZFD
FDMT
FDMT
Q4 25
$-11.7M
$28.6M
Q3 25
$1.7M
$-46.5M
Q2 25
$-10.1M
$-43.4M
Q1 25
$1.3M
$-47.8M
Q4 24
$-4.6M
$-134.6M
Q3 24
$9.6M
$-29.4M
Q2 24
$-12.4M
$-30.2M
Q1 24
$-13.3M
$-29.1M
Free Cash Flow
BZFD
BZFD
FDMT
FDMT
Q4 25
$-12.0M
$28.5M
Q3 25
$892.0K
$-46.6M
Q2 25
$-10.5M
$-43.4M
Q1 25
$956.0K
$-48.4M
Q4 24
$-4.7M
$-138.4M
Q3 24
$9.3M
$-31.2M
Q2 24
$-12.5M
$-30.6M
Q1 24
$-13.4M
$-29.8M
FCF Margin
BZFD
BZFD
FDMT
FDMT
Q4 25
-21.2%
33.5%
Q3 25
1.9%
-51765.6%
Q2 25
-22.7%
-289620.0%
Q1 25
2.7%
-345635.7%
Q4 24
-8.4%
-13837100.0%
Q3 24
16.7%
-1038966.7%
Q2 24
-30.5%
-611840.0%
Q1 24
-36.2%
-106421.4%
Capex Intensity
BZFD
BZFD
FDMT
FDMT
Q4 25
0.5%
0.1%
Q3 25
1.8%
101.1%
Q2 25
1.0%
440.0%
Q1 25
1.1%
4507.1%
Q4 24
0.3%
378600.0%
Q3 24
0.5%
59266.7%
Q2 24
0.3%
6980.0%
Q1 24
0.2%
2535.7%
Cash Conversion
BZFD
BZFD
FDMT
FDMT
Q4 25
1.47×
Q3 25
Q2 25
Q1 25
Q4 24
-0.15×
Q3 24
4.59×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BZFD
BZFD

Advertising$25.6M45%
Commerce And Other$16.3M29%
Content$14.7M26%

FDMT
FDMT

Segment breakdown not available.

Related Comparisons